Radiopharm secures ex Novartis exec as CEO ahead of IPO - (ASX:RAD)

Market Cap (10-Jun) $44,934,040 (0th)	Close (30-Jun) $0.105 -0.01 (-8.70%)	Volume (30-Jun) 1,951,148	Shortsold (26-May) 2,077,074 (0.06%) (491st)
52w High $0.040	52w Low $0.017	P/E -	EPS -0.02

[ARTICLE] Radiopharm secures ex Novartis exec as CEO ahead of IPO

MediaBot

September 6, 2021 12:29

A news article has been posted about Radiopharm Theranostics on the AFR. The article was published around September 6, 2021 12:29, on 6 September 2021 at 12:29pm.

Biotech veteran Paul Hopper has snagged a former Novartis executive to lead his latest soon-to-be-listed ventures, Radiopharm Theranostics. The company has appointed Riccardo Canevari as its first CEO,

Read Article

Recent Articles about ASX:RAD
31-Dec	Radiopharm Theranostics Limited (RADX) finance.yahoo.com
31-Dec	Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday benzinga.com
31-Dec	Radiopharm Theranostics: Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia finanznachrichten.de
31-Dec	Radiopharm enters co-development partnership with Lantheus markets.businessinsider.com
30-Dec	Radiopharm Theranostics (ASX:RAD) Partners with Lantheus to Advance Radiopharmaceutical Development kalkinemedia.com
30-Dec	Radiopharm Theranostics partners with Lantheus to advance radiopharmaceutical development grafa.com
28-Dec	Radiopharm Theranostics Ltd ADR au.investing.com
27-Dec	Radiopharm Theranostics Ltd ADR in.investing.com
27-Dec	Radiopharm Theranostics Ltd ADR in.investing.com
25-Dec	Radiopharm Theranostics gets HREC approval to start study of 177Lu-labelled RAD 202 for treatment of HER2-expressing solid tumours pharmabiz.com
Tracked

Find all articles about Radiopharm Theranostics, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.03	7,214,173	+0.00 (9.68%)
12-Sep	$0.03	19,871,583	+0.00 (6.90%)
11-Sep	$0.03	6,388,015	+0.00 (3.57%)
05-Sep	$0.03	2,120,535	0.00 (0.00%)
04-Sep	$0.03	4,651,023	+0.00 (5.66%)
03-Sep	$0.03	599,603	0.00 (5.36%)
29-Aug	$0.03	977,963	+0.00 (1.82%)
28-Aug	$0.03	1,712,009	+0.00 (1.85%)
22-Aug	$0.03	3,476,593	0.00 (10.00%)
21-Aug	$0.03	46,600,598	+0.00 (15.38%)
15-Aug	$0.03	2,085,119	+0.00 (6.12%)
14-Aug	$0.02	1,820,018	+0.00 (2.08%)
07-Aug	$0.02	1,331,698	+0.00 (4.35%)
31-Jul	$0.02	1,851,822	+0.00 (4.55%)
30-Jul	$0.02	3,321,092	0.00 (0.00%)
11 up, 2 down, and 2 flat days

High $0.12	Low $0.10	Trades 57	Turnover $206,557	Volume 1,951,148
30 June 2023 at 4:10pm

High $0.12	Low $0.10	Trades 57	Turnover $206,557	Volume 1,951,148
30 June 2023 at 4:10pm

Radiopharm Theranostics Health Care

$0.105 -0.010 (-8.70%)

RADIOPHARM THERANOSTICS LIMITED Class Pend

[ARTICLE] Radiopharm secures ex Novartis exec as CEO ahead of IPO

MediaBot

$0.105 -0.010 (-8.70%)

Followers

Prices

Announcements

End of Day Prices

RAD Radiopharm Theranostics Health Care

$0.105 -0.010 (-8.70%)

RAD RADIOPHARM THERANOSTICS LIMITED Class Pend

[ARTICLE] Radiopharm secures ex Novartis exec as CEO ahead of IPO

MediaBot

$0.105 -0.010 (-8.70%)

Followers

Prices

Announcements

End of Day Prices

Radiopharm Theranostics Health Care

RADIOPHARM THERANOSTICS LIMITED Class Pend